Cancer Page 603
More in Cancer
Triple-Negative Breast Cancer: pCR and Prognosis
Learn how a tumor’s response to initial treatment helps determine the long-term prognosis for patients with triple-negative breast cancer.
What Is 2-HG and How Does It Cause Cancer?
Explore how gene mutations cause a common metabolite, 2-HG, to accumulate and promote cancer by altering a cell’s epigenetic code and halting its development.
What Are RNF2 Compounds and How Do They Fight Cancer?
Learn how the RNF2 protein regulates gene activity. In some cancers, its overproduction silences protective genes, a process new compounds aim to reverse.
Tks5: The Scaffold Protein Behind Cancer’s Spread
Learn how the Tks5 scaffold protein acts as a molecular platform, assembling the components that allow cells to become invasive and drive disease progression.
Radioactive Iodine Treatment Success Rate for Thyroid Cancer
This clinical overview of radioactive iodine treatment explains how efficacy is determined and the patient-specific variables that contribute to a positive prognosis.
APL Leukemia Relapse After 5 Years: Causes and Outlook
An uncommon event, a late APL relapse has a distinct biological basis that often contributes to a favorable outlook with modern targeted therapies.
The Myt1 Protein: Role in Cell Division and Cancer
Explore the Myt1 protein, a fundamental regulator of cell division. Understand how its role in maintaining genetic stability also makes it a target for cancer therapy.
KIT Exon 11 Mutation: Significance, Diagnosis & Treatment
A specific genetic alteration, the KIT exon 11 mutation, is a key biomarker that directly influences treatment pathways and outcomes for certain cancers.
Glioblastoma Growth Rate: Factors and Progression
Explore the biological drivers of glioblastoma progression, from its unique infiltrative nature to the key molecular markers that determine its course.
The p53 DNA Binding Domain and Its Role in Cancer
The p53 protein’s DNA binding domain is central to tumor suppression. Its structural integrity directly governs its ability to regulate cell fate.
CD19 CAR-T Cell Therapy: What It Is & How It Works
Explore the fundamentals of CD19 CAR-T cell therapy, a targeted immunotherapy that re-engineers a patient’s own immune cells to fight B-cell malignancies.
What Is EGFR 131 Targeted Cancer Therapy?
Explore how targeted radiotherapy uses a guiding molecule to deliver a radioactive payload, providing a precise treatment for cancers driven by the EGFR protein.
IDH1 R132H Mutation: Cancer Driver and Therapeutic Target
Learn how the IDH1 R132H mutation alters enzyme function to drive cancer, creating a specific vulnerability that can be addressed by targeted therapies.
ALK Fusion: Cancers, Detection, and Targeted Therapy
Learn how identifying an ALK gene fusion provides a clear path for treatment, guiding the use of targeted therapies to manage specific types of cancer.